Attention-Based Protein Encoder for Drug Compound Identification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for identifying drug compounds targeting proteins in tissue cells are inefficient and lack effective strategies for optimizing compound affinity to specific protein sequences.
Innovation Solution
A neural network model comprising an attention-based protein encoder and a molecular decoder, pretrained in autoencoder architectures, is trained using reinforcement learning to generate compound data with high affinity to target proteins, optimizing reward values through iterative training processes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If traditional methods are used for identifying drug compounds, then the process is simple, but the efficiency and optimization of compound affinity to specific protein sequences are poor
Solution Approach 1:
The system segments the drug compound identification process into distinct functional modules: an attention-based protein encoder that processes protein sequences, a molecular decoder that generates compound structures, and a reinforcement learning component that optimizes affinity. This segmentation allows each module to be specialized and optimized independently, improving overall efficiency while managing complexity through modular architecture.
Solution Approach 2:
The patent introduces latent space representations as intermediaries between the protein encoder and molecular decoder. The protein encoder transforms input sequences into latent vector representations, which then serve as conditional inputs for the molecular decoder. This intermediary representation layer enables efficient information transfer and optimization without requiring direct complex interactions between all system components.
2Manufacturing precision
If reinforcement learning training is implemented to optimize compound affinity, then the affinity optimization improves, but the training time and computational resources increase
Solution Approach 1:
The system performs preliminary encoding of protein sequences into latent space representations using the pretrained attention-based protein encoder before the reinforcement learning optimization begins. This preliminary action prepares the input data in an optimized format, reducing the computational burden during the iterative reinforcement learning training process and enabling faster convergence to high-affinity compounds.
Solution Approach 2:
The reinforcement learning component implements a feedback mechanism where the affinity between generated compounds and target proteins is evaluated and used to update the molecular decoder's policy. This feedback loop allows the system to iteratively improve compound affinity by learning from previous generations, with the attention mechanism enabling efficient computation of affinity scores that provide meaningful gradients for policy optimization.
3Measurement precision
If attention-based encoding is used for protein sequences, then the understanding of protein structure improves, but the computational complexity increases
Solution Approach 1:
The attention-based protein encoder extracts key features and latent representations from protein sequences by applying attention mechanisms that weigh the importance of different amino acid positions. This extraction process transforms complex sequential data into condensed latent vectors that capture essential structural and functional information, achieving high encoding precision while reducing the dimensionality passed to subsequent modules.
Data Source
AI summary
Methods and systems are provided for identifying drug compounds for targeting proteins in tissue cells. Such a method includes providing a neural network model which comprises an attention-based protein encoder and a molecular decoder. The protein encoder is pretrained in an autoencoder architecture to encode an input protein sequence into an output vector in a latent space representing proteins. The molecular decoder is pretrained in an autoencoder architecture to generate compound data, defining a compound molecule, from an input vector in a latent space representing molecules. The protein encoder and molecular decoder are coupled such that the input vector of the molecular decoder is dependent on the output vector of the protein encoder for an input protein sequence.